Latest filing published 29 Sept 2022 for Cognition Therapeutics INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Golden Seeds Cognition Therapeutics LLC: trading record in brief
This profile gathers the share dealings of Golden Seeds Cognition Therapeutics LLC in Cognition Therapeutics Inc. We count 8 filings; the first trade dates from 13 October 2021 and the latest from 27 September 2022.
The open-market record consists of 1 sale worth €342, with no purchase. Outside the open market, there are 1 share grant.
The latest filing, published on 29 September 2022, reports a transaction in Cognition Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Golden Seeds Cognition Therapeutics LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,489,682 shares0Common StockSEC:0001062993-22-020050:0
- 273,321 sharesCommon StockSEC:0001104659-21-126904:0
2 of 2 declarations
